Stock Events

Stock Events

SciSparc 

$6.61
82
-$0.03-0.45% 19:43 Today

Statistics

Day High
7.55
Day Low
6.5
52W High
80.1
52W Low
2.98
Volume
239,303
Avg. Volume
927,658
Mkt Cap
3.79M
P/E Ratio
0.05
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-17.91
-11.94
-5.97
0
Expected EPS
0
Actual EPS
-0.7

Financials

-1,467.76%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
856,000Revenue
-12.56MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SPRC. It's not an investment recommendation.
NVIDIA
11
NVDA
Palantir Technologies
11
PLTR
Netflix
11
NFLX
Microsoft
10
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap195.15M
Corbus Pharmaceuticals works on cannabinoid drug development, targeting similar therapeutic areas as SciSparc, making them direct competitors.
Aurora Cannabis
ACB
Mkt Cap232.98M
Aurora Cannabis is a major player in the cannabis industry, whose medical cannabis products could compete with SciSparc's cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap430.6M
Canopy Growth Corporation operates in the cannabis and cannabinoid-derived product market, posing competition to SciSparc's product offerings.
Tilray Brands
TLRY
Mkt Cap642.5M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing with SciSparc in multiple markets.
Curaleaf
CURLF
Mkt Cap2.5B
Curaleaf Holdings is a leading U.S. provider of consumer products in cannabis, with a broad product portfolio that could compete with SciSparc's therapeutic offerings.

About

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Show more...
CEO
Oz Adler
Employees
3
Country
Israel
ISIN
IL0010951403

Listings

XNAS
US
SPRC
BOATS
BOATS
SPRC.BOATS

0 Comments

Share your thoughts

FAQ

What is SciSparc stock price today?▼
The current price of SPRC is $6.61 USD — it has decreased by -0.45% in the past 24 hours. Watch SciSparc stock price performance more closely on the chart.
What is SciSparc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange SciSparc stocks are traded under the ticker SPRC.
Is SciSparc stock price growing?▼
SPRC stock has fallen by -3.59% compared to the previous week, the month change is a +31.5% rise, over the last year SciSparc has showed a -83.91% decrease.
What is SciSparc market cap?▼
Today SciSparc has the market capitalization of 3.79M
What were SciSparc earnings last quarter?▼
SPRC earnings for the last quarter are -0.7 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SciSparc revenue for the last year?▼
SciSparc revenue for the last year amounts to 856,000 USD.
What is SciSparc net income for the last year?▼
SPRC net income for the last year is -12.56M USD.
How many employees does SciSparc have?▼
As of August 18, 2026, the company has 3 employees.
In which sector is SciSparc located?▼
SciSparc operates in the Health & Wellness sector.
When did SciSparc complete a stock split?▼
The last stock split for SciSparc was on March 04, 2026 with a ratio of 1:9.
Where is SciSparc headquartered?▼
SciSparc is headquartered in Tel Aviv, Israel.